跳到正文
原文
Endpoints News 生物医药· Elizabeth Cairns·· 2026-09-30AI 评分41

#EASD26:Zealand 与 Roche 的胰淀素类似物中剂量减重效果最佳,落后于 Lilly

#EASD26: Zealand and Roche's amylin works best at middle dose, trails Lilly's

AI 导读

在 EASD26 上公布的 Zealand Pharma 与 Roche 的胰淀素类似物 II 期肥胖试验中,中剂量组减重效果最佳,但仍落后于 Lilly 同类产品,结果被认为令人失望。

正文

MI­LAN — Weight loss with Zealand Phar­ma and Roche’s amylin ana­log was re­gard­ed as dis­ap­point­ing when its Phase 2 obe­si­ty tri­al re­port­ed

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

来源:Endpoints News 生物医药 · endpoints.news